Texas City Chemicals, Inc.
(Site Profile/Docket Number 112)
Location: Texas City, Texas
Also known as: American Oil Co., Borden, Inc., Smith-Douglass, Amoco Chemical Company
Special Exposure Cohort Petition Information
The Special Exposure Cohort (SEC) is a unique category of employees established by the Act (42 CFR Part 83). Claims compensated under the SEC do not have to go through the dose reconstruction process. To qualify for compensation under the SEC, a covered employee must meet specific requirements (e.g., must have at least one of 22 “specified cancers,” and have worked for a specified time period at one of the SEC sites). Classes of employees and work sites can be considered for addition to the SEC through a NIOSH petition process. More information about the Special Exposure Cohort can be found on our Frequently Asked Questions page.
Open/Active SEC Petitions
To date, there are no open/active SEC petitions from Texas City Chemicals, Inc..
Class(es) Added to the SEC
-
All Atomic Weapons Employer employees who worked at Texas City Chemicals, Inc., from October 5, 1953, through September 30, 1955, for a number of work days aggregating at least 250 work days, occurring either solely under this employment or in combination with work days within the parameters established for one or more other classes of employees included in the Special Exposure Cohort.
Note: This class was established from Petition 88
Petitions Qualified for Evaluation
Below is a list of the petitions that qualified for evaluation. Select a petition on the list to view the table for that particular petition.
Petition 88 (Jan 1, 1952 to Dec 31, 1956)
Steps in Petition Process: | Petition Details: |
---|---|
Date Received |
March 13, 2007 |
Date Qualified for Evaluation |
August 17, 2007 |
Summary of Information in Petition |
Location: Texas City, Texas Job Titles and/or Job Duties: All employees Period of Employment: January 1, 1952 through December 31, 1956 Note: The information above is what qualified for evaluation. During our evaluation of whether dose reconstructions can adequately be completed for the above job titles and period of employment, information may cause NIOSH to change some the dates or job titles/duties. Therefore, as this petition proceeds through the SEC petition process and if an SEC class is proposed, the proposed class may not exactly match the above information. |
Copy of the Petition Received |
|
Federal Register Notice Announcing that a Mallinckrodt Chemical Co., Destrehan St. Plant SEC Petition has met the Minimum Qualifications for Review and Evaluation |
|
SEC Petition Evaluation Report |
|
Evaluation Report Sent to the Advisory Board |
February 1, 2008 |
Petition Discussed by the Advisory Board |
The Advisory Board discussed the petition on November 17, 2010, April 7, 2008, and June 26, 2008, during its regular meetings. |
Advisory Board Recommendation on SEC Petition |
December 8, 2010 [33 KB (2 pages)] |
HHS Letters to Congress Regarding the SEC Petition |
January 6, 2011 [75 KB (9 pages)] |
HHS Designation of Additional Members to the SEC |
January 6, 2011 [33 KB (4 pages)] |
Federal Register Notice: Designation Regarding a Class of Employees for Addition to the Special Exposure Cohort |
January 21, 2011 [41 KB (1 page)] |
Effective Date for the SEC Class |
February 5, 2011 |
Federal Register Notice: Final Effect of Designation of a Class of Employees for Addition to the Special Exposure Cohort |
February 11, 2011 [49 KB (1 page)] |
Letter to DOL Regarding the Addition of a New Class of Employees to the SEC |
February 7, 2011 [18 KB (1 page)] |
SEC Petitions Not Qualifying for Evaluation
There was one additional petition received but it did not qualify for evaluation. The petition did not meet the minimum petition requirements for evaluation.
Worker Outreach Activities
Based on a recommendation from the Advisory Board to provide workers and site experts with opportunities to participate in developing the technical documents used in dose reconstruction, NIOSH established a Worker Outreach Program.
At Worker Outreach Meetings, current and former DOE and AWE employees have opportunities to obtain information about Site Profiles, Technical Basis Documents, and Technical Information Bulletins, and to provide information for consideration and possible use in dose reconstruction. This process is valuable to ensure that the technical documents used in dose reconstruction contain correct and useful information.
Below are the Worker Outreach Activities for the Texas City Chemicals, Inc.:
-
November 15, 2007
Town Hall Meeting on Texas City Chemicals, Inc.Captain’s Room of the Nessler Center2010 5th Avenue NorthTexas City, Texas
7:00 p.m. to 9:00 p.m.
Former workers, as well as family members, are invited and encouraged to attend.
Purpose: This meeting is an opportunity for former workers, and their families, to hear about NIOSH’s responsibilities under Part B of EEOICPA, including its dose reconstruction program and the SEC petition process. Please note this meeting is not an opportunity to discuss individual claim status; however, representatives from NIOSH and the Department of Labor will be available to answer general questions related to EEOICPA.
-
October 18, 2007
Meeting with former workersInternational Union of Operating Engineers Local 564 hallTexas City, Texas
Final Minutes
Advisory Board Work Group on Texas City Chemicals, Inc.
This Work Group will consider the conditions under which “surrogate” data can be used as a valid substitute for actual data for a given site. The Work Group will seek to establish the type and importance of various parameters (e.g., type of nuclide, amounts of material, chemical and physical forms, processes, working conditions, and other such parameters) that impact on worker dose, and will consider the extent to which such parameters at one site may apply to other sites. The Work Group may also consider the extent to which theoretical considerations can be properly used to bound dosed in the absence of actual workplace measurements. The Work Group should strive to develop a policy recommendation that can be adopted by the Board regarding the use of surrogate data. This Work Group was asked to consider the application of surrogate data criteria to the Texas City Chemicals, Inc., site in relation to the SEC petition for that facility.
Work Group Members:
- James Malcolm Melius, M.D., Dr. P.H. (Chair)
- Josie Beach
- James E. Lockey, M.D., M.S.
- Wanda I. Munn
Meeting Information:
-
November 5, 2010
Teleconference Meeting of the Advisory Board’s Work Group on the Use of Surrogate DataTime/Location:
1:00 p.m. Eastern Standard Time (EST)
Meeting Type: Teleconference; Public, No Comment PeriodTeleconference: +1-866-659-0537
Participant Code: 9933701Available Meeting Items:
-
May 13, 2010
Teleconference Meeting of the Advisory Board’s Work Group on the Use of Surrogate DataTime/Location:
1:00 p.m. Eastern Standard Time (EST)
Meeting Type: Teleconference; Public, No Comment PeriodTeleconference: +1-866-659-0537
Participant Code: 9933701Available Meeting Items:
- January 11, 2010
Teleconference Meeting of the Advisory Board’s Work Group on the Use of Surrogate Data1:00 p.m. Eastern Standard Time (EST)
Meeting Type: Teleconference; Public, No Comment PeriodTeleconference: +1-866-659-0537
Participant Code: 9933701Available Meeting Items:
- An agenda will be provided at a later date.
- Transcript [194 KB (92 pages)]
-
May 8, 2009
Teleconference Meeting of the Advisory Board’s Work Group on the Use of Surrogate DataTime/Location:
1:00 p.m. Eastern Standard Time (EST)
Meeting Type: Teleconference; Public, No Comment PeriodTeleconference: +1-866-659-0537
Participant Code: 9933701Available Meeting Items:
-
June 9, 2008
Teleconference Meeting of the Advisory Board’s Work Group on Surrogate DataTime/Location:
11:30 a.m. Eastern Standard Time (EST)
Meeting type: Teleconference; Open to Public; No Public Comment PeriodTeleconference: +1-866-659-0537
Participant Code: 9933701Available Meeting Items:
- An agenda will be provided at a later date.
- Transcript [133 KB (34 pages)]
Pre-Decisional Document Policy
Please note that as part of the procedures and processes of the Advisory Board’s Work Groups, several kinds of pre-decisional documents may be developed. These pre-decisional documents, such as white papers, matrices, working drafts, etc., are distributed among Work Group members as research and background tools to facilitate discussion and deliberation. Although discussion during a public meeting may cover pre-decisional documents, these documents often are not further revised or finalized, and thus do not reflect the final determination or evaluation of the Advisory Board and its Work Groups. Additionally, some pre-decisional documents not otherwise posted on the website may contain sensitive information, which would require an interested party to obtain such documents by filing a Freedom of Information Act (FOIA) request with the CDC/ATSDR FOIA office at foiarequests@cdc.gov.
Advisory Board and NIOSH Comments and Discussion Papers on Texas City Chemicals, Inc.
The Texas City Chemicals, Inc. discussion papers listed below are working documents prepared by NIOSH or its contractor for use in discussions with the Advisory Board on Radiation and Worker Health or its Working Groups or Subcommittees. Draft, preliminary, interim, and white paper documents are not final NIOSH or Advisory Board (or their technical support and review contractors) positions unless specifically marked as such. These documents represent preliminary positions taken on technical issues prepared by NIOSH or its contractor.
The discussion papers have been reviewed to identify and redact any information that is protected by the Privacy Act 5 USC §552a and have been cleared for distribution.
- Draft: A Focused Review of the NIOSH Evaluation Report for the Texas City Chemical Company SEC Petition [300 KB (44 pages)]
Contract No. 200-2004-03805
Task Order No. 5
July 2008
Public Comments on Texas City Chemicals, Inc. Documents
How to Submit Comments
Comments on Texas City Chemicals, Inc. Documents can be submitted to the NIOSH Docket Officer electronically by email at nioshdocket@cdc.gov or printed comments can be mailed to:
NIOSH Docket Office
Robert A. Taft Laboratories, MS-C34
1090 Tusculum Avenue
Cincinnati, OH 45226
Please include the Site Profile/Docket Number (112) on all comments.
Comments Received
-
Letter to the Advisory Board from Congressman Pete Olson, regarding Texas City Chemicals SEC petition (NIOSH SEC-00088) [80 KB (2 pages)]
October 1, 2010 - Comments from Daniel W. McKeel, Jr., M.D., on the Texas City Chemicals, Inc., SEC Petition (NIOSH SEC-00088) [85 KB (3 pages)]
July 26, 2010 - Comments from Daniel W. McKeel, Jr., M.D., on the Texas City Chemicals, Inc., SEC Petition Evaluation Report (NIOSH SEC-00088) [94 KB (2 pages)]
June 24, 2010 - Comments from Daniel W. McKeel, Jr., M.D., on the Texas City Chemicals, Inc., SEC Petition (NIOSH SEC-00088) [17 KB (1 page)]
January 7, 2010
Document Archive for Texas City Chemicals, Inc.
- Page last reviewed: September 28, 2015
- Page last updated: September 26, 2014
- Content source:
- National Institute for Occupational Safety and Health Division of Compensation Analysis and Support